Regeneron Pharmaceuticals
REGN
REGN
618 hedge funds and large institutions have $24.9B invested in Regeneron Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 83 funds opening new positions, 222 increasing their positions, 211 reducing their positions, and 97 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
7% less capital invested
Capital invested by funds: $26.9B → $24.9B (-$1.94B)
14% less first-time investments, than exits
New positions opened: 83 | Existing positions closed: 97
31% less call options, than puts
Call options by funds: $594M | Put options by funds: $861M
Holders
618
Holding in Top 10
12
Calls
$594M
Puts
$861M
Top Buyers
| 1 | +$585M | |
| 2 | +$247M | |
| 3 | +$211M | |
| 4 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
+$135M |
| 5 |
Two Sigma Advisers
New York
|
+$110M |
Top Sellers
| 1 | -$418M | |
| 2 | -$293M | |
| 3 | -$153M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$97.2M |
| 5 |
Millennium Management
New York
|
-$95M |